1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Chronic Disease Market Trends
  5. > Coronary Artery Disease (CAD)-Pipeline Insights, 2014

SUMMARY
DelveInsight’s,“ Coronary Artery Disease (CAD)-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Coronary Artery Disease (CAD). This report provides information on the therapeutic development based on the Coronary Artery Disease (CAD) dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Data Sources

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.

Scope
- The report provides a snapshot of the global therapeutic landscape of Coronary Artery Disease (CAD)
- The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
- Coverage of the Coronary Artery Disease (CAD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Coronary Artery Disease (CAD) and also provide company profiling
- The report also gives the information of dormant and discontinued pipeline projects
- Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to buy
- Complete Pipeline intelligence and complete understanding over therapeutics development for Coronary Artery Disease (CAD)
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Devise corrective measures for pipeline projects by understanding Coronary Artery Disease (CAD) pipeline depth and focus of Indication therapeutics
- Developing strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Develop and design in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
- Gaining a Full Picture of the Competitive Landscape for Evidence based Decisions

Table Of Contents

Coronary Artery Disease (CAD)-Pipeline Insights, 2014
Table of Contents
- Coronary Artery Disease (CAD) Overview
- Coronary Artery Disease (CAD) Pipeline Therapeutics
- Coronary Artery Disease (CAD) Therapeutics under Development by Companies
- Coronary Artery Disease (CAD) Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Coronary Artery Disease (CAD) Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Coronary Artery Disease (CAD) Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Coronary Artery Disease (CAD) Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Coronary Artery Disease (CAD) - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Coronary Artery Disease (CAD) - Discontinued Products
- Coronary Artery Disease (CAD) - Dormant Products
- Companies Involved in Therapeutics Development for Coronary Artery Disease (CAD)
- Appendix
- Methodology
- Contact Us
- Disclaimer

List of Tables

- Number of Products under Development for Coronary Artery Disease (CAD), 2014
- Number of Products under Development by Companies
- Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2014
- Comparative Analysis Mid Clinical Stage Products (Phase II), 2014
- Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2014
- Comparative Analysis Discovery and Pre-Clinical Stage Products, 2014
- Drug Candidates Profiles
- Coronary Artery Disease (CAD) Assessment by Monotherapy Products
- Coronary Artery Disease (CAD) Assessment by Combination Products
- Coronary Artery Disease (CAD) Assessment by Route of Administration
- Coronary Artery Disease (CAD) Assessment by Stage and Route of Administration
- Coronary Artery Disease (CAD) Assessment by Molecule Type
- Coronary Artery Disease (CAD) Assessment by Stage and Molecule Type
- Coronary Artery Disease (CAD) Therapeutics - Discontinued Products
- Coronary Artery Disease (CAD) Therapeutics - Dormant Products
- Products under Development by Companies, 2014

List of Figures

- Number of Products under Development for Coronary Artery Disease (CAD), 2014
- Late Clinical Stage Products (Filed and Phase III), 2014
- Mid Clinical Stage Products (Phase II), 2014
- Early Clinical Stage Products (Phase I and IND Filed), 2014
- Discovery and Pre-Clinical Stage Products, 2014
- Coronary Artery Disease (CAD) Assessment by Monotherapy Products
- Coronary Artery Disease (CAD) Assessment by Combination Products
- Coronary Artery Disease (CAD) Assessment by Route of Administration
- Coronary Artery Disease (CAD) Assessment by Stage and Route of Administration
- Coronary Artery Disease (CAD) Assessment by Molecule Type
- Coronary Artery Disease (CAD) Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
 Coronary Artery Disease (CAD)-Pipeline Insights, 2016

Coronary Artery Disease (CAD)-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Coronary Artery Disease (CAD)-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Coronary Artery Disease ...

Global Bioabsorbable Stent Market - Growth, Trends and Forecast (2016 - 2021)

Global Bioabsorbable Stent Market - Growth, Trends and Forecast (2016 - 2021)

  • $ 4250
  • Industry report
  • September 2016
  • by Mordor Intelligence LLP

The global bioabsorbable stent market is estimated at USD XX billion in 2016 and projected to reach USD XX billion by 2021, growing at a CAGR of XX% during the forecast period. According to WHO, cardiovascula ...

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • July 2016
  • by Global Data

Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Occlusive Coronary Artery Disease Global Clinical Trials Review, H2, 2016" provides ...


Download Unlimited Documents from Trusted Public Sources

Type 2 Diabetes and Cholesterol Statistics in the UK

  • November 2016
    9 pages
  • Type 2 Diabetes  

    Cholesterol  

    Lipid Modifying...  

  • United Kingdom  

    United States  

View report >

Therapy Market and Hypertension Statistics in Asia and the US

  • November 2016
    26 pages
  • Therapy  

    Hypertension  

    Cardiovascular ...  

  • Asia  

    United States  

    Europe  

View report >

Chronic Disease Statistics in the UK

  • November 2016
    7 pages
  • Pathology  

    Chronic Disease  

  • United Kingdom  

View report >

Related Market Segments :

Coronary Artery Disease

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.